ARTICLE | Distillery Therapeutics
Therapeutics: microRNA-3188 (MIR3188); forkhead box O1 (FOXO1)
April 28, 2016 7:00 AM UTC
Patient sample, cell culture and mouse studies suggest promoting expression of MIR3188 or FOXO1 could help treat nasopharyngeal carcinoma (NPC). In patients, low tumor levels of MIR3188 correlated wit...